// App-Quantinova.ai

CTP2 2015 ASA : NAVIGATE ESUS: A Multicenter, Randomized, Double-blind, Double-dummy, Active-comparator, Event-driven, Superiority Phase III Study Of Prevention Of Recurrent Stroke And Systemic Embolism In Patients With A Recent Embolic Stroke Of Undetermined Source (ESU

Researchers

Presenter

  • Keith Muir

Principal Investigators

  • Rubens J Gagliardi

  • Sebastian F Ameriso

  • Pablo M Lavados

  • Mukul Sharma

  • Hardi Mundl

  • Scott D Berkowitz

  • Robert G Hart

  • Stuart J Connolly

Medical Centers

  • U Chile, Santiago, Chile

  • Inst for Clinical Res, FLENI, Buenos Aires, Argentina

  • Population Health Rsch Institute, McMaster Univ, Hamilton, Canada

  • University of Glasgow, Glasgow, United Kingdom

  • Santa Casa de Sao Paulo Medical School, Sao Paulo, Brazil

  • University of Pennsylvania, Philadelphia, PA

Locations

  • Brazil

  • Canada

  • Argentina

  • United Kingdom

  • United States

  • Chile

Companies

  • Bayer

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Arrhythmia

  • Coronary Artery Disease

  • Ischemic stroke

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • superiority

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved